Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-27 @ 2:23 AM
Study NCT ID:
NCT05253066
Status:
UNKNOWN
Last Update Posted:
2022-02-23
First Post:
2022-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Sponsor:
Shengjing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-13
First Submit QC Date:
None
Study First Post Date:
2022-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-02-23
Last Update Post Date Type:
ACTUAL